Skip to content

A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease

A Randomized Controlled Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01646333
Enrollment
32
Registered
2012-07-20
Start date
2012-07-31
Completion date
2015-12-31
Last updated
2016-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment, Parkinson's Disease

Keywords

Parkinson Disease, Mild Cognitive Impairment, Cognition, Executive Function, Learning, Memory, Problem Solving

Brief summary

This randomized, controlled trial (RCT) evaluates the benefits of memory and problem solving training compared to supportive therapy in individuals with Parkinson's Disease with Mild Cognitive Impairment (MCI) and their support persons. Participants will be randomly assigned to receive memory and problem solving training or supportive therapy for 2-months. A 6-month follow up evaluation will establish if benefits remain over time. Impact of these therapies on thinking abilities, physical health, and patient and support person ratings of thinking skills, mood and quality of life will be evaluated. The memory and problem solving training is hypothesized to result in greater improvements and/or stability of function on neuropsychological tests of attention, working memory, learning, and memory skills compared to the supportive therapy condition. Both conditions are hypothesized to result in improved mood and quality of life ratings. Results from this study will determine whether memory and problem solving therapies and supportive therapy are easily used by and beneficial for individuals with Parkinson's Disease and Mild Cognitive Impairment. If positive benefit is observed, information from this study will be used to further optimize these therapies for larger trials designed to evaluate the value of the therapies for individuals with Parkinson's Disease and their support persons.

Detailed description

The memory and problem solving training consists of a day calendar manual and note taking system and problem solving techniques. The supportive therapy offers patients and support persons the opportunity to discuss and reflect upon both Parkinson's Disease and non-Parkinson's Disease related problems.

Interventions

BEHAVIORALMemory and Problem-Solving Intervention

8 weekly 1 hour sessions of memory compensation and problem-solving strategies

BEHAVIORALSupportive Therapy

8 weekly 1 hour sessions of non-directive supportive therapy.

Sponsors

Michael J. Fox Foundation for Parkinson's Research
CollaboratorOTHER
Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Parkinson's Disease * Clinical diagnosis of Mild Cognitive Impairment

Exclusion criteria

* Clinical diagnosis of Dementia * Clinical diagnosis of other Parkinson's Disease-associated comorbid conditions (e.g., severe anxiety, depression, excessive daytime sleepiness, or psychosis) that significantly influence cognitive testing

Design outcomes

Primary

MeasureTime frameDescription
California Verbal Learning Test-II Long Delay Free Recall Scaled Score Change Over 10 WeeksChange from Baseline in California Verbal Learning Test-II Long Delay Free Recall Scaled Score at 10 weeksChange in California Verbal Learning Test-II Long Delay Free Recall Scaled Score from Baseline and 10 weeks

Secondary

MeasureTime frameDescription
Linear Analog Scale Assessment Overall Well Being Raw Score Change Over 10 WeeksChange from Baseline in Linear Analog Scale Assessment Overall Well Being Raw Score at 10 weeksChange in Linear Analog Scale Assessment Overall Well Being Raw Score from Baseline and 10 weeks

Other

MeasureTime frameDescription
California Verbal Learning Test-II Long Delay Free Recall Scaled Score Change Over 6 MonthsChange from Baseline in California Verbal Learning Test-II Long Delay Free Recall Scaled Score at 6 monthsChange in California Verbal Learning Test-II Long Delay Free Recall Scaled Score from Baseline and 6 months
Linear Analog Scale Assessment Overall Well Being Raw Score Change Over 6 MonthsChange from Baseline in Linear Analog Scale Assessment Overall Well Being Raw Score at 6 monthsChange in Linear Analog Scale Assessment Overall Well Being Raw Score from Baseline and 6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026